n-aminomethylmorpholine 3,3-diethyl-2,4-pyridinedione ( dkmm ) applied in doses of 100 mg/ng i. v. in cases of pentylenetetrazol epilepsy leads to a rise in the convulsive thresholds ( n , n ) by 1.5 and two times , respectively .
C0030903
pentylenetetrazol
C0014544
epilepsy